2020
DOI: 10.1007/s00520-020-05311-5
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
51
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(51 citation statements)
references
References 26 publications
0
51
0
Order By: Relevance
“…In addition, CPT-11 is also used to treat esophageal cancer, cervical cancer, leukemia, etc. The toxic and side effects during treatment are mainly intestinal reactions, adverse reactions of the blood system, and complex symptoms such as hair loss, fatigue, mucositis, and skin toxicity (including hand-foot syndrome) [ 20 ]. Existing studies believe that, from the perspective of drug metabolism, this is mainly due to the toxicity of the central metabolite of CPT-11.…”
Section: Concepts Related To the Management Effect Of Cancer Patients...mentioning
confidence: 99%
“…In addition, CPT-11 is also used to treat esophageal cancer, cervical cancer, leukemia, etc. The toxic and side effects during treatment are mainly intestinal reactions, adverse reactions of the blood system, and complex symptoms such as hair loss, fatigue, mucositis, and skin toxicity (including hand-foot syndrome) [ 20 ]. Existing studies believe that, from the perspective of drug metabolism, this is mainly due to the toxicity of the central metabolite of CPT-11.…”
Section: Concepts Related To the Management Effect Of Cancer Patients...mentioning
confidence: 99%
“…Twelve studies (31%) out of 42 did not find any statistically significant correlation between adherence levels and clinical outcome. [14][15][16][17][18][19][20][21][22][23][24][25] In two studies (5%) a correlation was found for only one of the outcomes considered (quality of life and EFS) while no correlation was found for the other outcomes (respectively major molecular response and PFS and OS). 26,27 In five studies (9%), the authors reported that there was a correlation between outcome and adherence, but that it was not statistically significant.…”
Section: Calculation Methods and Correlationsmentioning
confidence: 99%
“…14 In one study, non-adherence was estimated according to missed doses reported by the patient along with the reasons for not taking the prescribed doses without specifying cut-offs. 15…”
Section: Medication Adherencementioning
confidence: 99%
See 2 more Smart Citations